Safeguard Scientifics (SFE) 13.06 $SFE
Safeguard Scientifics Announces Second Quarter 2016 Financial Results
PR Newswire - Thu Jul 28, 5:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced financial results for the three- and six-months ended June 30, 2016, as well as continued achievement of developmental milestones by Safeguard's 27 current partner companies.
SFE: 13.06 (+0.22)
Trice Medical Appoints Mark Foster Chief Commercialization Officer
PR Newswire - Thu Jul 07, 7:00AM CDT
Trice Medical today announced the appointment of Mark Foster as chief commercialization officer and vice president, worldwide sales. In this newly created role, Foster will lead the company's product commercialization and sales worldwide, working closely with the product development, operations, sales and marketing teams to solidify Trice Medical's position as a leader in the orthopedic industry while identifying and executing upon the company's growth and strategic opportunities. Foster joins Trice Medical's executive team and reports directly to the company's CEO, Jeff O'Donnell, Sr.
SFE: 13.06 (+0.22)
Martina F. Aufiero Joins Safeguard Scientifics As Managing Director, Technology
PR Newswire - Mon Jun 20, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced that Martina F. Aufiero has joined the company as Senior Vice President and Managing Director, Technology. Ms. Aufiero will be responsible for sourcing and deploying capital in early- and growth-stage technology companies, providing operational oversight and driving successful exits for Safeguard's partner companies.
SFE: 13.06 (+0.22)
Aktana Raises $17.5M To Fund Growing Decision Support Business In Life Sciences
PR Newswire - Wed Jun 08, 7:00AM CDT
Aktana, the pioneer in decision support for global life science companies, today announced a $17.5 million financing led by Safeguard Scientifics, Inc. (NYSE: SFE), which will initially deploy up to $8.25 million. Existing investor Starfish Ventures and others are also participating in the financing. Closing is expected on or before June 16, 2016. Aktana will use proceeds from the financing primarily for continued product development and international expansion. The company plans to open offices in China and Europe, adding to its current offices in San Francisco, New York City, and Tokyo.
SFE: 13.06 (+0.22)
Technology Innovator Patrick Flynn Joins Aventura as COO
PR Newswire - Tue Jun 07, 8:00AM CDT
Aventura, the leading provider of situational awareness technology for the healthcare industry, today announced the appointment of technology innovator Patrick Flynn as Chief Operating Officer. Flynn brings more than 30 years of experience leading and transforming global technology and operations organizations to Aventura including his most recent role as Chief Technology Officer for Phytel, the leader in population health management. In 2015, Phytel was acquired by IBM as part of the Watson Health line of business.
SFE: 13.06 (+0.22), IBM: 160.58 (-0.87)
Vectura and Propeller Health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases
PR Newswire - Tue May 24, 5:00AM CDT
Vectura Group plc (LSE: VEC) and Propeller Health, the leading digital health solution for respiratory medicine, today announced a collaboration to develop inhalers that combine Vectura's proven dry powder inhaler ("DPI"
technology with Propeller's FDA-cleared digital health platform.
VEC: 31.33 (+0.05), SFE: 13.06 (+0.22)
Safeguard Scientifics Names New Chairman of the Board
PR Newswire - Thu May 19, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that Robert J. Rosenthal, Ph.D. has been elected Chairman of the Board of the Company. Dr. Rosenthal has served on Safeguard's board of directors since 2007. Dr. Rosenthal succeeds Andrew E. Lietz, who served on the Company's board of directors since 2003 and as its Chair since 2009. Jack L. Messman also retired yesterday from Safeguard's board of directors after 22 years of service.
SFE: 13.06 (+0.22)
Rocky Brands Selects Clutch to Lace Up Innovative Customer Loyalty Program
BusinessWire - Tue May 10, 8:00AM CDT
How does a leading footwear designer with multiple, diverse brands strengthen its relationship with hipsters and hunters simultaneously? By developing distinct customer loyalty programs tailored for individual product lines. To do this, Rocky Brands, a maker of premium outdoor, work, western, duty and military footwear, has partnered with Clutch, a pioneering customer marketing technology provider.
SFE: 13.06 (+0.22), RCKY: 10.51 (-0.39)
American Capital (ACAS) Q1 Earnings Beat on Lower Costs
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:54AM CDT
American Capital, Ltd. (ACAS) reported first-quarter 2016 net operating income per share of 31 cents, beating the Zacks Consensus Estimate of 25 cents.
SFE: 13.06 (+0.22), ACAS: 16.49 (-0.01), AINV: 5.64 (-0.07), OFS: 13.48 (-0.23)
Safeguard Scientifics reports 1Q loss
Automated Insights - Thu Apr 28, 5:43AM CDT
RADNOR, Pa. (AP) _ Safeguard Scientifics Inc. (SFE) on Thursday reported a loss of $15.5 million in its first quarter.
SFE: 13.06 (+0.22)
Safeguard Scientifics Announces First Quarter 2016 Financial Results
PR Newswire - Thu Apr 28, 5:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced first quarter 2016 financial results. Safeguard's partner companies achieved significant developmental milestones.
SFE: 13.06 (+0.22)
Capital One, Fifth Third, PNC, TD, and Wells Fargo Invest in Transactis
PR Newswire - Sun Apr 17, 11:00AM CDT
Five of the largest U.S. commercial banks -- Capital One, Fifth Third, PNC, TD, and Wells Fargo -- and Safeguard Scientifics announced they have invested a total of $30 million in Transactis, a leading provider of electronic billing and payment solutions. Each bank, along with Safeguard, invested an equal amount in Transactis as part of a Series E financing, demonstrating the banks' continued leadership in payments innovation. Transactis' technology reaches more than 100 million households and businesses in North America.
SFE: 13.06 (+0.22), FITB: 18.58 (-0.20), TD: 42.88 (-0.40), COF: 66.30 (-0.73), WFC: 47.70 (-0.11), PNC: 81.66 (-0.76)
5 Stocks with Surging Estimates in Q1 Earnings Season
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 9:03AM CDT
S&P 500 companies are likely to witness a 10.3% year-over-year decline in earnings in the quarter. The 5 mentioned stocks are expected to post earnings growth despite the oddities.
SFE: 13.06 (+0.22), CPN: 13.45 (+0.02), EPZM: 9.87 (-0.48), MDXG: 7.53 (-0.18), AUY: 5.84 (+0.07)
Transactis Appoints Payments Veterans to Board of Advisors
PR Newswire - Tue Apr 05, 11:12AM CDT
Transactis, a leading provider of electronic billing and payment solutions, is proud to announce the addition of Patty Thorell from Comcast (ret.), and Matt Koetzle from Genuine Parts Company (ret.) to its Board of Advisors.
SFE: 13.06 (+0.22), GPC: 100.57 (-1.41)
American Capital (ACAS) Buys Back Shares Worth $296.5M
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 1:20PM CDT
American Capital Ltd. (ACAS) announced the repurchase of its common stock worth $296.5 million. The company bought back a total of 21.2 million shares of its common stock at an average price of $13.96 per share.
SFE: 13.06 (+0.22), ACAS: 16.49 (-0.01), BKCC: 8.25 (-0.05), OFS: 13.48 (-0.23)
Safeguard Scientifics To Release First Quarter 2016 Financial Results On Thursday, April 28th
PR Newswire - Mon Mar 28, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) will release its financial results for the first quarter 2016 prior to market open on Thursday, April 28, 2016.
SFE: 13.06 (+0.22)
Propeller Health and Boehringer Ingelheim Announce New Partnership Focused on Improving Adherence and Care Management for People Living with COPD and Asthma
PR Newswire - Wed Mar 23, 6:00AM CDT
Propeller Health, the leading digital health solution for respiratory medicine, and Boehringer Ingelheim Pharmaceuticals Inc., a global pharmaceutical company and leading provider of inhaled medications for serious respiratory diseases, today announced a first-of-its-kind commercial partnership that aims to use digital health tools and services to help people living with chronic obstructive pulmonary disease (COPD) and asthma better manage their disease.
SFE: 13.06 (+0.22)
Safeguard Scientifics Partner Company Putney To Be Acquired For $200M
PR Newswire - Tue Mar 15, 2:59AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that its partner company, Putney, Inc., signed a definitive agreement to be acquired by Dechra Holdings US Inc., a subsidiary of Dechra Pharmaceuticals Plc (LON
PH), for $200 million, in cash. The transaction is expected to close in April 2016, pending satisfactory completion of customary closing conditions and regulatory approval. Safeguard expects to receive aggregate initial cash proceeds of $58 million, which excludes an amount of additional proceeds to be held in escrow, representing an approximate 3.9x cash-on-cash return and 42% IRR. Safeguard deployed $14.9 million in Putney since September 2011 and prior to the acquisition had a 28% primary ownership position.
SFE: 13.06 (+0.22)
Safeguard Scientifics Shares Down 21.2% Since SmarTrend's Sell Call (SFE)
Comtex SmarTrend(R) - Thu Feb 04, 1:08PM CST
SmarTrend identified a Downtrend for Safeguard Scientifics (NYSE:SFE) on November 13th, 2015 at $16.20. In approximately 3 months, Safeguard Scientifics has returned 21.21% as of today's recent price of $12.76.
SFE: 13.06 (+0.22)
Transactis is Keeping Banks in the Center of Payments
PR Newswire - Thu Feb 04, 12:00PM CST
After years of watching non-bank vendors encroach upon the banking industry's prized payments space, more top financial institutions have contracted with Transactis to provide them and their corporate clients with the industry's leading electronic billing and payment solutions (EBPP).
SFE: 13.06 (+0.22)
Safeguard Scientifics Announces Second Quarter 2016 Financial Results
PR Newswire - Thu Jul 28, 5:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced financial results for the three- and six-months ended June 30, 2016, as well as continued achievement of developmental milestones by Safeguard's 27 current partner companies.
SFE: 13.06 (+0.22)
Trice Medical Appoints Mark Foster Chief Commercialization Officer
PR Newswire - Thu Jul 07, 7:00AM CDT
Trice Medical today announced the appointment of Mark Foster as chief commercialization officer and vice president, worldwide sales. In this newly created role, Foster will lead the company's product commercialization and sales worldwide, working closely with the product development, operations, sales and marketing teams to solidify Trice Medical's position as a leader in the orthopedic industry while identifying and executing upon the company's growth and strategic opportunities. Foster joins Trice Medical's executive team and reports directly to the company's CEO, Jeff O'Donnell, Sr.
SFE: 13.06 (+0.22)
Martina F. Aufiero Joins Safeguard Scientifics As Managing Director, Technology
PR Newswire - Mon Jun 20, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced that Martina F. Aufiero has joined the company as Senior Vice President and Managing Director, Technology. Ms. Aufiero will be responsible for sourcing and deploying capital in early- and growth-stage technology companies, providing operational oversight and driving successful exits for Safeguard's partner companies.
SFE: 13.06 (+0.22)
Aktana Raises $17.5M To Fund Growing Decision Support Business In Life Sciences
PR Newswire - Wed Jun 08, 7:00AM CDT
Aktana, the pioneer in decision support for global life science companies, today announced a $17.5 million financing led by Safeguard Scientifics, Inc. (NYSE: SFE), which will initially deploy up to $8.25 million. Existing investor Starfish Ventures and others are also participating in the financing. Closing is expected on or before June 16, 2016. Aktana will use proceeds from the financing primarily for continued product development and international expansion. The company plans to open offices in China and Europe, adding to its current offices in San Francisco, New York City, and Tokyo.
SFE: 13.06 (+0.22)
Technology Innovator Patrick Flynn Joins Aventura as COO
PR Newswire - Tue Jun 07, 8:00AM CDT
Aventura, the leading provider of situational awareness technology for the healthcare industry, today announced the appointment of technology innovator Patrick Flynn as Chief Operating Officer. Flynn brings more than 30 years of experience leading and transforming global technology and operations organizations to Aventura including his most recent role as Chief Technology Officer for Phytel, the leader in population health management. In 2015, Phytel was acquired by IBM as part of the Watson Health line of business.
SFE: 13.06 (+0.22), IBM: 160.58 (-0.87)
Vectura and Propeller Health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases
PR Newswire - Tue May 24, 5:00AM CDT
Vectura Group plc (LSE: VEC) and Propeller Health, the leading digital health solution for respiratory medicine, today announced a collaboration to develop inhalers that combine Vectura's proven dry powder inhaler ("DPI"
technology with Propeller's FDA-cleared digital health platform. VEC: 31.33 (+0.05), SFE: 13.06 (+0.22)
Safeguard Scientifics Names New Chairman of the Board
PR Newswire - Thu May 19, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that Robert J. Rosenthal, Ph.D. has been elected Chairman of the Board of the Company. Dr. Rosenthal has served on Safeguard's board of directors since 2007. Dr. Rosenthal succeeds Andrew E. Lietz, who served on the Company's board of directors since 2003 and as its Chair since 2009. Jack L. Messman also retired yesterday from Safeguard's board of directors after 22 years of service.
SFE: 13.06 (+0.22)
Rocky Brands Selects Clutch to Lace Up Innovative Customer Loyalty Program
BusinessWire - Tue May 10, 8:00AM CDT
How does a leading footwear designer with multiple, diverse brands strengthen its relationship with hipsters and hunters simultaneously? By developing distinct customer loyalty programs tailored for individual product lines. To do this, Rocky Brands, a maker of premium outdoor, work, western, duty and military footwear, has partnered with Clutch, a pioneering customer marketing technology provider.
SFE: 13.06 (+0.22), RCKY: 10.51 (-0.39)
American Capital (ACAS) Q1 Earnings Beat on Lower Costs
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:54AM CDT
American Capital, Ltd. (ACAS) reported first-quarter 2016 net operating income per share of 31 cents, beating the Zacks Consensus Estimate of 25 cents.
SFE: 13.06 (+0.22), ACAS: 16.49 (-0.01), AINV: 5.64 (-0.07), OFS: 13.48 (-0.23)
Safeguard Scientifics reports 1Q loss
Automated Insights - Thu Apr 28, 5:43AM CDT
RADNOR, Pa. (AP) _ Safeguard Scientifics Inc. (SFE) on Thursday reported a loss of $15.5 million in its first quarter.
SFE: 13.06 (+0.22)
Safeguard Scientifics Announces First Quarter 2016 Financial Results
PR Newswire - Thu Apr 28, 5:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) today announced first quarter 2016 financial results. Safeguard's partner companies achieved significant developmental milestones.
SFE: 13.06 (+0.22)
Capital One, Fifth Third, PNC, TD, and Wells Fargo Invest in Transactis
PR Newswire - Sun Apr 17, 11:00AM CDT
Five of the largest U.S. commercial banks -- Capital One, Fifth Third, PNC, TD, and Wells Fargo -- and Safeguard Scientifics announced they have invested a total of $30 million in Transactis, a leading provider of electronic billing and payment solutions. Each bank, along with Safeguard, invested an equal amount in Transactis as part of a Series E financing, demonstrating the banks' continued leadership in payments innovation. Transactis' technology reaches more than 100 million households and businesses in North America.
SFE: 13.06 (+0.22), FITB: 18.58 (-0.20), TD: 42.88 (-0.40), COF: 66.30 (-0.73), WFC: 47.70 (-0.11), PNC: 81.66 (-0.76)
5 Stocks with Surging Estimates in Q1 Earnings Season
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 9:03AM CDT
S&P 500 companies are likely to witness a 10.3% year-over-year decline in earnings in the quarter. The 5 mentioned stocks are expected to post earnings growth despite the oddities.
SFE: 13.06 (+0.22), CPN: 13.45 (+0.02), EPZM: 9.87 (-0.48), MDXG: 7.53 (-0.18), AUY: 5.84 (+0.07)
Transactis Appoints Payments Veterans to Board of Advisors
PR Newswire - Tue Apr 05, 11:12AM CDT
Transactis, a leading provider of electronic billing and payment solutions, is proud to announce the addition of Patty Thorell from Comcast (ret.), and Matt Koetzle from Genuine Parts Company (ret.) to its Board of Advisors.
SFE: 13.06 (+0.22), GPC: 100.57 (-1.41)
American Capital (ACAS) Buys Back Shares Worth $296.5M
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 1:20PM CDT
American Capital Ltd. (ACAS) announced the repurchase of its common stock worth $296.5 million. The company bought back a total of 21.2 million shares of its common stock at an average price of $13.96 per share.
SFE: 13.06 (+0.22), ACAS: 16.49 (-0.01), BKCC: 8.25 (-0.05), OFS: 13.48 (-0.23)
Safeguard Scientifics To Release First Quarter 2016 Financial Results On Thursday, April 28th
PR Newswire - Mon Mar 28, 8:00AM CDT
Safeguard Scientifics, Inc. (NYSE: SFE) will release its financial results for the first quarter 2016 prior to market open on Thursday, April 28, 2016.
SFE: 13.06 (+0.22)
Propeller Health and Boehringer Ingelheim Announce New Partnership Focused on Improving Adherence and Care Management for People Living with COPD and Asthma
PR Newswire - Wed Mar 23, 6:00AM CDT
Propeller Health, the leading digital health solution for respiratory medicine, and Boehringer Ingelheim Pharmaceuticals Inc., a global pharmaceutical company and leading provider of inhaled medications for serious respiratory diseases, today announced a first-of-its-kind commercial partnership that aims to use digital health tools and services to help people living with chronic obstructive pulmonary disease (COPD) and asthma better manage their disease.
SFE: 13.06 (+0.22)
Safeguard Scientifics Partner Company Putney To Be Acquired For $200M
PR Newswire - Tue Mar 15, 2:59AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that its partner company, Putney, Inc., signed a definitive agreement to be acquired by Dechra Holdings US Inc., a subsidiary of Dechra Pharmaceuticals Plc (LON
PH), for $200 million, in cash. The transaction is expected to close in April 2016, pending satisfactory completion of customary closing conditions and regulatory approval. Safeguard expects to receive aggregate initial cash proceeds of $58 million, which excludes an amount of additional proceeds to be held in escrow, representing an approximate 3.9x cash-on-cash return and 42% IRR. Safeguard deployed $14.9 million in Putney since September 2011 and prior to the acquisition had a 28% primary ownership position. SFE: 13.06 (+0.22)
Safeguard Scientifics Shares Down 21.2% Since SmarTrend's Sell Call (SFE)
Comtex SmarTrend(R) - Thu Feb 04, 1:08PM CST
SmarTrend identified a Downtrend for Safeguard Scientifics (NYSE:SFE) on November 13th, 2015 at $16.20. In approximately 3 months, Safeguard Scientifics has returned 21.21% as of today's recent price of $12.76.
SFE: 13.06 (+0.22)
Transactis is Keeping Banks in the Center of Payments
PR Newswire - Thu Feb 04, 12:00PM CST
After years of watching non-bank vendors encroach upon the banking industry's prized payments space, more top financial institutions have contracted with Transactis to provide them and their corporate clients with the industry's leading electronic billing and payment solutions (EBPP).
SFE: 13.06 (+0.22)
